Clinical Trial Update: Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing adding adefovir dipivoxil versus switching to entecavir in lamivudine-resistant chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)
• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: Korea University | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED